Literature DB >> 17693158

Stroke prevention in elderly patients with atrial fibrillation.

David Garcia1, Elaine Hylek.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693158     DOI: 10.1016/S0140-6736(07)61208-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  The new oral anticoagulants.

Authors:  F W A Verheugt
Journal:  Neth Heart J       Date:  2010-06       Impact factor: 2.380

Review 2.  Novel oral anticoagulants to prevent stroke in atrial fibrillation.

Authors:  Freek W A Verheugt
Journal:  Nat Rev Cardiol       Date:  2010-03       Impact factor: 32.419

3.  Stroke prevention: age alone does not rule out warfarin.

Authors:  Sarah-Anne Schumann; Bernard Ewigman
Journal:  J Fam Pract       Date:  2007-11       Impact factor: 0.493

4.  Also the very elderly benefit from warfarin in atrial fibrillation.

Authors:  F W A Verheugt
Journal:  Neth Heart J       Date:  2007-12       Impact factor: 2.380

5.  Using an Atrial Fibrillation Decision Support Tool for Thromboprophylaxis in Atrial Fibrillation: Effect of Sex and Age.

Authors:  Mark H Eckman; Gregory Y H Lip; Ruth E Wise; Barbara Speer; Megan Sullivan; Nita Walker; Brett Kissela; Matthew L Flaherty; Dawn Kleindorfer; Peter Baker; Robert Ireton; Dave Hoskins; Brett M Harnett; Carlos Aguilar; Anthony Leonard; Lora Arduser; Dylan Steen; Alexandru Costea; John Kues
Journal:  J Am Geriatr Soc       Date:  2016-05       Impact factor: 5.562

Review 6.  Current issues in thromboprophylaxis in the elderly.

Authors:  Parminder S Chaggar; Kevin S Channer
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 7.  Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice.

Authors:  Ian N Sabir; Gareth D K Matthews; Christopher L-H Huang
Journal:  Postgrad Med J       Date:  2013-02-12       Impact factor: 2.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.